Treatments | S (%) | U (%) | FCR (mg) | IVDMD (%) | IVNDFD (%) | IVADFD (%) |
---|---|---|---|---|---|---|
T1 | 0 | 2 | 0 | 59.56 | 50.17 | 27.59 |
T2 | 0 | 4 | 0 | 60.80 | 52.03 | 28.49 |
T3 | 1 | 2 | 0 | 61.64 | 52.18 | 27.58 |
T4 | 1 | 4 | 0 | 62.73 | 53.45 | 28.38 |
T5 | 2 | 2 | 0 | 62.65 | 52.03 | 28.65 |
T6 | 2 | 4 | 0 | 62.96 | 53.33 | 29.42 |
T7 | 0 | 2 | 200 | 59.69 | 49.62 | 28.46 |
T8 | 0 | 4 | 200 | 61.95 | 54.91 | 28.94 |
T9 | 1 | 2 | 200 | 63.98 | 53.63 | 28.70 |
T10 | 1 | 4 | 200 | 62.77 | 54.51 | 29.29 |
T11 | 2 | 2 | 200 | 62.60 | 51.43 | 30.27 |
T12 | 2 | 4 | 200 | 63.58 | 53.84 | 31.34 |
T13 | 0 | 2 | 300 | 60.82 | 51.45 | 29.47 |
T14 | 0 | 4 | 300 | 62.18 | 54.79 | 30.01 |
T15 | 1 | 2 | 300 | 62.48 | 53.66 | 29.81 |
T16 | 1 | 4 | 300 | 63.01 | 54.35 | 30.47 |
T17 | 2 | 2 | 300 | 63.44 | 53.44 | 31.16 |
T18 | 2 | 4 | 300 | 60.80 | 55.94 | 31.86 |
T19 | 0 | 2 | 400 | 61.30 | 50.29 | 28.94 |
T20 | 0 | 4 | 400 | 62.69 | 53.66 | 29.62 |
T21 | 1 | 2 | 400 | 62.21 | 54.35 | 29.21 |
T22 | 1 | 4 | 400 | 62.79 | 51.61 | 29.64 |
T23 | 2 | 2 | 400 | 63.07 | 54.05 | 30.25 |
T24 | 2 | 4 | 400 | 63.07 | 54.05 | 30.51 |
SEM | 0.75 | 1.32 | 0.27 | |||
S (%) | ||||||
0 | 60.82b | 52.15b | 29.51b | |||
1 | 62.68a | 53.78a | 29.71b | |||
2 | 63.06a | 53.21a | 30.51a | |||
P-Value | <0.0001 | 0.044 | <0.0001 | |||
U (%) | ||||||
2 | 61.48b | 51.95b | 29.65b | |||
4 | 62.50a | 54.14a | 30.17a | |||
P-Value | 0.009 | 0.0005 | 0.0001 | |||
FCR (mg) | ||||||
0 | 61.72 | 52.20 | 29.80 | |||
200 | 62.42 | 52.99 | 30.03 | |||
300 | 62.56 | 54.02 | 30.05 | |||
400 | 62.06 | 52.99 | 29.76 | |||
P-Value | 0.067 | 0.158 | 0.159 | |||
Interaction | ||||||
S*U | 0.029 | 0.150 | 0.669 | |||
S*FCR | 0.644 | 0.959 | 0.714 | |||
U*FCR | 0.775 | 0.845 | 0.953 | |||
S*U*FCR | 0.341 | 0.972 | 0.956 |